A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients
NCT07199777 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-09-30
Summary
The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.
Conditions
Interventions
- DRUG
-
SNP318
Once daily, oral administration
- DRUG
-
Once daily, oral administration
Sponsors & Collaborators
-
SciNeuro
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-30
- Primary Completion
- 2026-11-30
- Completion
- 2027-03-31
- FDA Drug
- Yes
More Related Trials
-
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
NCT01168258 ·Status: TERMINATED
-
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
NCT01506895 ·Status: COMPLETED ·Phase: PHASE2
-
Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
NCT05959304 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
NCT03511898 ·Status: COMPLETED ·Phase: PHASE1
-
Sirolimus to Treat Diabetic Macular Edema
NCT00711490 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
NCT02002403 ·Status: COMPLETED ·Phase: PHASE2
-
Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
NCT06599684 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
NCT06908876 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
NCT00308477 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Study to YD312 Tablet in Patients With Diabetic Macular Edema
NCT03635814 ·Status: UNKNOWN ·Phase: PHASE2
-
The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
NCT04151407 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1
-
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
NCT00536692 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
NCT00308542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
NCT01918371 ·Status: COMPLETED
-
Treatment of Refractory Diabetic Macular Edema With Infliximab
NCT00505947 ·Status: TERMINATED ·Phase: PHASE3
-
Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study
NCT03597815 ·Status: UNKNOWN
-
A Dose Escalation Study of IBI324 in Subjects With Diabetic Macular Edema
NCT05489718 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
NCT00959725 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
NCT01319487 ·Status: COMPLETED ·Phase: PHASE2
-
A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy
NCT07198815 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Research Study in Patients With Persistent Macular Edema
NCT00035906 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
NCT05393284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
NCT01702441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN